Purchase Order 75N91024P00402
Award Date 4/27/24
Potential Completion Date 7/26/24
Potential Value $17K
Federal Agency
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
North Bethesda, MD 20852, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to Becton, Dickinson And Company (BD) for a maintenance agreement. The contract has a potential value of $112,554.60 and was awarded on April 13, 2020, with a completion date of April 12, 2021. BD is a global medical technology company that provides instruments, reagents, and services to support biomedical research and clinical...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for a maintenance agreement covering a BD LSR II flow cytometer with lasers and computer. The contract has a ceiling value of $20,628 and a completion date of November 17, 2014. BD is a global medical technology company that provides instruments, reagents, and services for biomedical research...
- This is a $105,926.44 firm fixed-price delivery order awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health, to Becton, Dickinson and Company (BD) under the FSS-66 Scientific Equipment and Services federal supply schedule. The contract is for a SERVICE AGREEMENT with a period of performance through February 28, 2025. This delivery order is not a set-aside contract. BD is a global medical technology company that provides specialized equipment,...
- This is a federal contract award to Becton, Dickinson and Company (BD) by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), for maintenance services on government-owned Becton Dickinson instrumentation. The $141,480.00 firm fixed-price purchase order supports the work of the NCI's Center for Cancer Research, Experimental Immunology Branch. The contract has no set-aside designation and was awarded on February 1, 2017, with a completion date of January...
- The National Cancer Institute awarded a purchase order to Becton, Dickinson and Company (BD Biosciences) for a maintenance agreement valued at $21,222.00, with an award date of January 16, 2020 and ultimate completion on January 15, 2021. Place of performance is Bethesda, Maryland. The order is structured as a firm fixed-price purchase order with no set-aside applied. BD Biosciences supplies flow cytometry instrumentation and maintenance services to federal biomedical research and diagnostic...
- This is a firm fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Becton, Dickinson and Company (BD) for $107,265.00. The contract does not have a set-aside designation. BD is a global medical technology company that provides a range of goods and services to U.S. government agencies, including specialized biomedical equipment, reagents, and laboratory supplies to support research and clinical...
- Becton, Dickinson and Company (BD) has been awarded a firm fixed price purchase order by the National Institutes of Health National Cancer Institute for $10,864.80. The contract calls for servicing an instrument used by approximately 75 personnel at the agency to conduct experiments involving costly reagents, animals, and extensive labor hours. Performance will take place in Bethesda, Maryland through April 2024. No set-aside designation was applied. This award is likely associated with...
- This is a $17,118.00 firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) to provide a service contract to maintain a flow cytometer. The contract period of performance is June 2, 2025 through June 1, 2026. No set-aside designation was used for this award. BD is a global medical technology company that develops, manufactures, and sells medical devices,...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Becton, Dickinson And Company (BD) for an annual service agreement to maintain BD flow cytometers, lasers, and accessories. The potential value of the contract is $178,744.32, with a completion date of March 31, 2023. The contract is not set aside for a specific business type. BD is a global medical technology...
- This is a purchase order contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Becton, Dickinson And Company (BD) for a maintenance agreement on FACFORESSA instruments. The contract is a firm fixed price contract with a potential value of $20,388.48. The contract does not have a set-aside designation. BD is a global medical technology company that provides instruments, reagents, and services to support biomedical research and...